Medlive Technology Co (HKSE:02192) 3-Year EBITDA Growth Rate : 27.20% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Medlive Technology Co 3-Year EBITDA Growth Rate?

Medlive Technology Co's EBITDA per Share for the six months ended in Dec. 2023 was HK$0.23.

During the past 12 months, Medlive Technology Co's average EBITDA Per Share Growth Rate was 78.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 27.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 55.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of Medlive Technology Co was 63.30% per year. The lowest was 27.20% per year. And the median was 47.70% per year.

Competitive Comparison of Medlive Technology Co's 3-Year EBITDA Growth Rate

For the Medical Distribution subindustry, Medlive Technology Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medlive Technology Co's 3-Year EBITDA Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Medlive Technology Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Medlive Technology Co's 3-Year EBITDA Growth Rate falls into.

Medlive Technology Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Medlive Technology Co (HKSE:02192) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Medlive Technology Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Medlive Technology Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Medlive Technology Co (HKSE:02192) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medlive Technology Co Ltd (HKSE:02192) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1 Baijialou Chaoyang North Road, E1 Red Manor International Bonded Innovation Park, Chaoyang District, Beijing, CHN

Website

https://www.medlive.cn

Medlive is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms to specifically target physicians through different promotional channels. The company uses in-house and third-party content teams to produce advertising for its clients by profiling the user preferences of the physicians on the platform who drive procurement and prescription decisions. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and SaaS solution that help with medical conferences and clinical research. M3, Japan's leading digital healthcare marketing company owns 38.8% of Medlive through a joint venture.

Medlive Technology Co (HKSE:02192) Headlines

No Headlines